Advertisement

Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort

Published:November 07, 2022DOI:https://doi.org/10.1016/j.ejca.2022.09.026

      Highlights

      • About one-third of breast cancer survivors experience persistent severe fatigue.
      • Radiation therapy (RT) modalities are associated with severe global fatigue.
      • Internal mammary chain RT is associated with severe global fatigue at 1 year.
      • Normofractionated RT is associated with severe global fatigue at 1 year.
      • RT modalities are not associated with emotional and cognitive fatigue dimensions.

      Abstract

      Background

      Fatigue is a common and disabling symptom after breast cancer (BC) treatment, significantly impacting patients' quality of life. We aimed to assess the impact of radiation therapy (RT) modalities on fatigue one year after treatment among patients with early-stage BC.

      Methods

      We used CANTO-RT, a subcohort of CANcer TOxicity (CANTO; NCT01993498), a multicentric nationwide prospective cohort of stages I–III BC treated from 2012 to 2017. Our primary outcome was severe global fatigue 1 year after RT completion (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 score ≥40/100). The secondary outcomes included severe physical, emotional and cognitive fatigue (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-FA12). RT-related variables were used as independent variables. Multivariable logistic regression models assessed associations between RT-related variables and fatigue.

      Results

      The final analytic cohort included 3295 patients. The prevalence of severe global fatigue 1 year after treatment was 33.3%. Internal mammary chain RT (adjusted odds ratio [OR] 1.48 [95% confidence interval [CI] 1.03–2.13; p = 0.0355]) and normofractionated RT (adjusted OR 1.88 [95% CI 1.06–3.31; p = 0.0298]) were associated with increased odds of severe global fatigue. In addition, there was a significant association between normofractionated RT (adjusted OR 1.849 [95% CI 1.04–3.3; p = 0.0354]) and an increased likelihood of severe physical fatigue.

      Conclusion

      We found a significant association between internal mammary chain RT (versus No), normofractionated RT (versus hypofractionated RT) and increased likelihood of persistent severe global fatigue. Our data add to the current understanding of treatment-related factors affecting fatigue after BC and could lead to personalised interventions to improve the prevention and management of this disabling symptom.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H.
        • Ferlay J.
        • Siegel R.L.
        • Laversanne M.
        • Soerjomataram I.
        • Jemal A.
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2021; 71: 209-249
        • Coleman M.P.
        • Quaresma M.
        • Berrino F.
        • Lutz J.-M.
        • De Angelis R.
        • Capocaccia R.
        • et al.
        Cancer survival in five continents: a worldwide population-based study (CONCORD).
        Lancet Oncol. 2008; 9: 730-756
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2019.
        CA Cancer J Clin. 2019; 69: 7-34
        • Miller K.D.
        • Siegel R.L.
        • Lin C.C.
        • Mariotto A.B.
        • Kramer J.L.
        • Rowland J.H.
        • et al.
        Cancer treatment and survivorship statistics, 2016.
        CA Cancer J Clin. 2016; 66: 271-289
        • Bower J.E.
        Cancer-related fatigue—mechanisms, risk factors, and treatments.
        Nat Rev Clin Oncol. 2014; 11: 597-609
        • Bower J.E.
        • Ganz P.A.
        • Desmond K.A.
        • Rowland J.H.
        • Meyerowitz B.E.
        • Belin T.R.
        Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
        J Clin Oncol. 2000; 18 (743–743)
        • Abrahams H.J.G.
        • Gielissen M.F.M.
        • Schmits I.C.
        • Verhagen C.A.H.H.V.M.
        • Rovers M.M.
        • Knoop H.
        Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors.
        Ann Oncol. 2016; 27: 965-974
        • Ferreira A.R.
        • Di Meglio A.
        • Pistilli B.
        • Gbenou A.S.
        • El-Mouhebb M.
        • Dauchy S.
        • et al.
        Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
        Ann Oncol. 2019; 30: 1784-1795
        • Minton O.
        • Stone P.
        How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature.
        Breast Cancer Res Treat. 2008; 112: 5-13
        • Bower J.E.
        • Ganz P.A.
        • Desmond K.A.
        • Bernaards C.
        • Rowland J.H.
        • Meyerowitz B.E.
        • et al.
        Fatigue in long-term breast carcinoma survivors: a longitudinal investigation.
        Cancer. 2006; 106: 751-758
        • Koornstra R.H.T.
        • Peters M.
        • Donofrio S.
        • van den Borne B.
        • de Jong F.A.
        Management of fatigue in patients with cancer – a practical overview.
        Cancer Treat Rev. 2014; 40: 791-799
        • Joly F.
        • Lange M.
        • Dos Santos M.
        • Vaz-Luis I.
        • Di Meglio A.
        Long-term fatigue and cognitive disorders in breast cancer survivors.
        Cancers. 2019; 11: 1896
        • Veronesi U.
        • Marubini E.
        • Mariani L.
        • Galimberti V.
        • Luini A.
        • Veronesi P.
        • et al.
        Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial.
        Ann Oncol. 2001; 12: 997-1003https://doi.org/10.1023/A:1011136326943
      1. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
        Lancet. 2005; 366: 2087-2106
        • Smets E.
        • Visser M.
        • Willems-Groot A.
        • Garssen B.
        • Oldenburger F.
        • van Tienhoven G.
        • et al.
        Fatigue and radiotherapy: (A) experience in patients undergoing treatment.
        Br J Cancer. 1998; 78: 899-906
        • Geinitz H.
        • Zimmermann F.B.
        • Stoll P.
        • Thamm R.
        • Kaffenberger W.
        • Ansorg K.
        • et al.
        Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.
        Int J Radiat Oncol. 2001; 51: 691-698
        • Arpin D.
        • Perol D.
        • Blay J.-Y.
        • Falchero L.
        • Claude L.
        • Vuillermoz-Blas S.
        • et al.
        Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.
        J Clin Oncol. 2005; 23: 8748-8756
        • Thorsen L.B.J.
        • Offersen B.V.
        • Danø H.
        • Berg M.
        • Jensen I.
        • Pedersen A.N.
        • et al.
        DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer.
        J Clin Oncol. 2016; 34: 314-320
        • Budach W.
        • Kammers K.
        • Boelke E.
        • Matuschek C.
        Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
        Radiat Oncol. 2013; 8: 267
        • Hennequin C.
        • Bossard N.
        • Servagi-Vernat S.
        • Maingon P.
        • Dubois J.-B.
        • Datchary J.
        • et al.
        Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
        Int J Radiat Oncol. 2013; 86: 860-866
        • Meattini I.
        • Becherini C.
        • Boersma L.
        • Kaidar-Person O.
        • Marta G.N.
        • Montero A.
        • et al.
        European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
        Lancet Oncol. 2022; 23: e21-e31
        • Bower J.E.
        • Ganz P.A.
        • Irwin M.R.
        • Kwan L.
        • Breen E.C.
        • Cole S.W.
        Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?.
        J Clin Oncol. 2011; 29: 3517-3522
        • Vaz-Luis I.
        • Cottu P.
        • Mesleard C.
        • Martin A.L.
        • Dumas A.
        • Dauchy S.
        • et al.
        UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO).
        ESMO Open. 2019; 4e000562
        • Di Meglio A.
        • Havas J.
        • Soldato D.
        • Presti D.
        • Martin E.
        • Pistilli B.
        • et al.
        Development and validation of a predictive model of severe fatigue after breast cancer diagnosis: toward a personalized framework in survivorship care.
        J Clin Oncol. 2022; (JCO.21.01252)
        • Sprangers M.A.G.
        • Cull A.
        • Bjordal K.
        • Groenvold M.
        • Aaronson N.K.
        • EORTC Study Group on Quality of Life
        The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules.
        Qual Life Res. 1993; 2: 287-295
        • Weis J.
        • Tomaszewski K.A.
        • Hammerlid E.
        • Ignacio Arraras J.
        • Conroy T.
        • Lanceley A.
        • et al.
        International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12).
        109. J Natl Cancer Inst, 2017
        • Katz J.N.
        • Chang L.C.
        • Sangha O.
        • Fossel A.H.
        • Bates D.W.
        Can comorbidity be measured by questionnaire rather than medical record review?.
        Med Care. 1996; 34: 73-84
        • Zigmond A.S.
        • Snaith R.P.
        The hospital anxiety and depression scale.
        Acta Psychiatr Scand. 1983; 67: 361-370
        • Falk K.
        • Swedberg K.
        • Gaston-Johansson F.
        • Ekman I.
        Fatigue is a prevalent and severe symptom associated with uncertainty and sense of coherence in patients with chronic heart failure.
        Eur J Cardiovasc Nurs. 2007; 6: 99-104
        • Poortmans P.M.
        • Collette S.
        • Kirkove C.
        • Van Limbergen E.
        • Budach V.
        • Struikmans H.
        • et al.
        Internal mammary and medial supraclavicular irradiation in breast cancer.
        N Engl J Med. 2015; 373: 317-327
        • Whelan T.J.
        • Olivotto I.A.
        • Parulekar W.R.
        • Ackerman I.
        • Chua B.H.
        • Nabid A.
        • et al.
        Regional nodal irradiation in early-stage breast cancer.
        N Engl J Med. 2015; 373: 307-316
        • Tang C.
        • Liao Z.
        • Gomez D.
        • Levy L.
        • Zhuang Y.
        • Gebremichael R.A.
        • et al.
        Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.
        Int J Radiat Oncol. 2014; 89: 1084-1091
        • Haviland J.S.
        • Owen J.R.
        • Dewar J.A.
        • Agrawal R.K.
        • Barrett J.
        • Barrett-Lee P.J.
        • et al.
        The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
        Lancet Oncol. 2013; 14: 1086-1094
        • Murray Brunt A.
        • Haviland J.S.
        • Wheatley D.A.
        • Sydenham M.A.
        • Alhasso A.
        • Bloomfield D.J.
        • et al.
        Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
        Lancet. 2020; 395: 1613-1626
        • Puetz T.W.
        • Herring M.P.
        Differential effects of exercise on cancer-related fatigue during and following treatment.
        Am J Prev Med. 2012; 43: e1-e24
        • Gielissen M.F.M.
        • Verhagen S.
        • Witjes F.
        • Bleijenberg G.
        Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial.
        J Clin Oncol. 2006; 24: 4882-4887
        • Molassiotis A.
        • Bardy J.
        • Finnegan-John J.
        • Mackereth P.
        • Ryder D.W.
        • Filshie J.
        • et al.
        Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial.
        J Clin Oncol. 2012; 30: 4470-4476
        • Monk J.P.
        • Phillips G.
        • Waite R.
        • Kuhn J.
        • Schaaf L.J.
        • Otterson G.A.
        • et al.
        Assessment of tumor necrosis factor Alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
        J Clin Oncol. 2006; 24: 1852-1859
        • Tookman A.J.
        • Jones C.L.
        • DeWitte M.
        • Lodge P.J.
        Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab.
        Support Care Cancer. 2008; 16: 1131-1140